IL6 and colitis: The PCA has been reported to inhibit the production of inflammatory mediators, such as IL-6, TNF, IL-1β, and prostaglandin E2 (PGE2), potentially by suppressing the activation of NF-κB and extracellular signal-regulated kinase (ERK) in murine BV2 microglia cells and colitis mouse model.